12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

SK Chemicals Co. Ltd., Teijin sales and marketing update

Teijin launched Feburic febuxostat in Japan and Korea to treat hyperuricemia. Partner SK Chemicals will market the non-purine selective inhibitor of...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >